$ALM

Almonty clears final hurdle to start producing tungsten at South Korea mine

Almonty Industries (ALM) received South Korean approval to commercially process tungsten at the Sangdong mine, expected to produce 200,000 MTU/year. The company has invested over $100M to redevelop the site. Tungsten prices are high, and over 90% of Phase I production is contracted. ALM shares rose 6.43% to $14.73.

Original reporting
Published Sep 21, 2026, 7:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 7:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$ALM
Bullish
high confidence
Mentioned
$ALM
Relevance
8/10
AlphAI data visualization · based on mining.com
Decision brief

The 30-second read

$ALMBullishHigh
01

Why it matters

The approval enables the transition from ore to concentrate, unlocking a 4.41 million MTU off‑take agreement with Global Tungsten & Powers, and supports U.S. defense procurement rules effective Jan 2027.

02

Market read

The news removes a regulatory bottleneck, likely driving further share appreciation and influencing tungsten supply dynamics globally.

03

What to watch

Potential cost overruns in the underground redevelopment and competition from other non‑Chinese tungsten projects.

Relevance 8/10Novelty 8/10Timing: mid‑day Monday

Background

Almonty has invested >$100 million since acquiring the Sangdong project in 2015 and has been producing ore since mid‑2026.

Company-level read

Ticker impact

$ALMBullishHigh confidence
Context

Almonty Industries received South Korean government approval to commercially process tungsten concentrate, unlocking production of ~200,000 MTU per year.

Expected impact

Potential upside as shares may rally on the new production capability and 6% price jump.

Evidence & confidence

The approval is a primary, material event for a mid‑cap miner; the market already reacted positively, indicating further upside if production ramps as expected.

Market effects

Boosts the tungsten mining sector and may benefit downstream defense and high‑tech manufacturers seeking non‑Chinese supply.

Strengthens South Korea's position as a strategic tungsten processing hub.

Adds a Western‑addressed source of tungsten at a time of heightened geopolitical supply concerns.

Counterpoint

If production delays occur or off‑take contracts are not fully honored, the initial price rally could reverse.

Key entities

  • Almonty Industries

    NASDAQ‑listed tungsten miner receiving regulatory approval.

  • Global Tungsten & Powers LLC

    Off‑taker of Sangdong concentrate, part of Plansee Group.

Related articles

$ALMMed

Defense Stockpile Orders Send Explorers Back to Old Tungsten Camps

The U.S. Defense Logistics Agency awarded a $2B contract for tungsten supplies, with a $450M investment from the Department of War. GoldHaven Resources (CSE: GOH) completed drilling at its Kuhn tungsten-skarn target, intersecting skarn mineralization in two locations. Almonty Industries (NASDAQ: ALM) began commercial operations at its Sangdong plant, with 90% of Phase I production contracted. Guardian Metal (NYSE: GMTL) reported drilling results from its Tempiute project.

$ELMTMed

Technology Metals Report (10.04.2026): A Summit Without a Rare Earth Deal Leaves the West Buying Its Way to Supply

The U.S. and China failed to reach a rare earth supply deal during Xi Jinping's visit, leaving the West to secure supplies. Rare earth exports from China to the U.S. declined, with prices showing mixed trends. Elmet Group and Almonty Industries are expanding tungsten production. Glencore will partner with the U.S. strategic minerals reserve. Eramet plans to expand lithium production in Argentina. Processing capacity is also increasing, with Korea Zinc planning a U.S. smelter.

$ALMMed

Almirall, S.A.: Almirall Advances Skin Science and Shares New Evidence Across Its Dermatology Portfolio at EADV 2026

Almirall, S.A. (ALM) presented new clinical data at EADV 2026, showcasing advances in dermatology treatments. Key findings include sustained improvements in atopic dermatitis with lebrikizumab and benefits in psoriasis with tildrakizumab. The company also highlighted its commitment to medical dermatology through sponsorship and awareness campaigns.

$ALMMed

Almonty Industries ALM Stock Rallies On Tungsten Breakout

Almonty Industries (NASDAQ: ALM) stock rose 11.09% on positive tungsten market news and project progress. The company reported $42.99M in quarterly revenue, $1.22B in cash, and a share buyback plan. ALM secured inspection certificates for its Sangdong project in South Korea and expanded operations in Rwanda, positioning itself as a key tungsten supplier outside China.

$ALMHigh

Why is Almonty Industries stock rallying today?

Almonty Industries (ALM) stock rose 2.7% in pre-market trading to $12.74. Stifel initiated coverage with a Buy rating and $25 target, while Goldman Sachs gave a Neutral rating and $13 target. The company's Sangdong mine in South Korea received final certification for commercial operations, securing 90% of Phase I output under long-term agreements. The S&P 500, Dow Jones, and Nasdaq were up 0.3%, 0.3%, and 0.5% respectively.